Beth Faiman Ph.D, MSN, APRN-BC, AOCN
Cleveland Clinic Taussig Cancer Institute

Program

Black Americans have roughly twice the incidence of multiple myeloma as white Americans,
with recent studies finding that blacks are also less likely to receive the latest myeloma
treatments or combination therapies, and more likely to encounter delays in receiving
treatment, including transplants. Participants will learn about myeloma, including
symptoms and treatment options. Additional information will be provided on clinical trials
and the role they play in the treatment of myeloma. Resources available through
The Leukemia and Lymphoma Society will be reviewed.

We encourage you to invite your caregiver and family members.